|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | |
| A61K 9/00 | |||
| A61K 9/10 | |||
| A61K 9/16 | |||
| A61K 9/28 | |||
| A61K 9/48 |
| (11) | Number of the document | 1715856 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04815693.9 |
| Date of filing the European patent application | 2004-12-23 | |
| (97) | Date of publication of the European application | 2006-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2012-07-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/043678 |
| Date | 2004-12-23 |
| (87) | Number | WO 2005/065673 |
| Date | 2005-07-21 |
| (30) | Number | Date | Country code |
| 533517 P | 2003-12-31 | US |
| (72) |
BOEHM, Garth, US
DUNDON, Josephine, US
|
| (73) |
Actavis Group PTC ehf.,
Reykjavikurvegi 76-78, 220 Hafnarfjordur,
IS
|
| (54) | ATOMOXETINE FORMULATIONS |
| ATOMOXETINE FORMULATIONS |